Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.23.1
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Additional disclosures  
Total unrecognized compensation cost related to unvested equity awards | $ $ 35
Weighted average period of recognition related to unvested equity awards (in years) 1 year 2 months 12 days
Liberty SiriusXM Group  
Additional disclosures  
Common stock reserved for issuance 6,000,000.0
Liberty SiriusXM Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty SiriusXM Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty SiriusXM Group | Series C  
Number of options  
Outstanding at beginning of period 6,862,000
Granted 370,000
Exercised (213,000)
Forfeited/Cancelled (980,000)
Outstanding at end of period 6,039,000
Exercisable at end of period 3,722,000
WAEP  
Outstanding at beginning of period | $ / shares $ 39.83
Granted | $ / shares 31.19
Exercised | $ / shares 32.61
Forfeited/Cancelled | $ / shares 31.33
Outstanding at end of period | $ / shares 40.94
Exercisable at end of period | $ / shares $ 39.97
Additional disclosures  
Weighted average remaining life, outstanding 3 years 4 months 24 days
Weighted average remaining life, exercisable 2 years 7 months 6 days
Formula One Group  
Additional disclosures  
Common stock reserved for issuance 6,500,000
Formula One Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Series C  
Number of options  
Outstanding at beginning of period 7,086,000
Granted 71,000
Exercised (669,000)
Outstanding at end of period 6,488,000
Exercisable at end of period 5,002,000
WAEP  
Outstanding at beginning of period | $ / shares $ 36.18
Granted | $ / shares 75.12
Exercised | $ / shares 29.06
Outstanding at end of period | $ / shares 37.34
Exercisable at end of period | $ / shares $ 35.08
Additional disclosures  
Weighted average remaining life, outstanding 3 years 8 months 12 days
Weighted average remaining life, exercisable 3 years 6 months
Aggregate intrinsic value, outstanding | $ $ 243
Aggregate intrinsic value, exercisable | $ $ 199
Braves Group  
Additional disclosures  
Common stock reserved for issuance 3,000,000.0
Braves Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 0
Braves Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Braves Group | Series C  
Number of options  
Outstanding at beginning of period 3,108,000
Exercised (146,000)
Forfeited/Cancelled (4,000)
Outstanding at end of period 2,958,000
Exercisable at end of period 1,357,000
WAEP  
Outstanding at beginning of period | $ / shares $ 26.17
Exercised | $ / shares 18.32
Forfeited/Cancelled | $ / shares 22.75
Outstanding at end of period | $ / shares 26.57
Exercisable at end of period | $ / shares $ 25.68
Additional disclosures  
Weighted average remaining life, outstanding 4 years 3 months 18 days
Weighted average remaining life, exercisable 4 years 1 month 6 days
Aggregate intrinsic value, outstanding | $ $ 21
Aggregate intrinsic value, exercisable | $ $ 11